₹1,910.10
-22.15 (-1.15%)
As of 18 Sept 2026, Emcure Pharmaceuticals Ltd share price is ₹1,910.10. The stock opened at ₹1,910.10 and had closed at ₹1,932.25 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,260.10 and a high of ₹2,047.40. In terms of performance, Emcure Pharmaceuticals Ltd share price has increased by 26.11% over the past six months and has increased by 43.93% over the last year.
EMCURE Stock Price Chart
Emcure Pharmaceuticals Ltd Overview
Market cap₹36,657 Crs
Volume4,902
Prev. Close₹1,932.25
Year range₹1,260.10 - ₹2,047.40
ISININE168P01015
About EMCURE
Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally.
Emcure Pharmaceuticals Ltd Historical Performance
1 Month Return3.07%
6 Month Return32.44%
3 Year Return-
3 Month Return11.31%
1 Year Return42.02%
5 Year Return-
Emcure Pharmaceuticals Ltd Fundamentals
ROCE(TTM)19.88%
P/E Ratio (TTM)45.24
P/B Ratio9.88
Debt to Equity0.43
ROE19.75%
EPS (TTM)43.63
Dividend Yield0.19%
Book Value195.60
Profit Margin14.79%
Operating Margin17.62%
Emcure Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 5,452.71 | 4,500.73 | 3,635.92 | 3,232.44 | 3,519.92 |
| EBITDA | 1,309.19 | 765.64 | 570.83 | 557.69 | 927.35 |
| Net Profit | 732.96 | 317.13 | 160.83 | 160.06 | 446.81 |
| EPS | 38.67 | 16.95 | 8.89 | 9.07 | 24.66 |
Emcure Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,885.78 |
| Resistance 1 (R1) | 1,996.63 |
| Pivot Point | 1,950.17 |
Emcure Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 04-Sep-2026 | 05-May-2026 | 04-Sep-2026 | Final | ₹3.60 |
| 14-Aug-2025 | 22-May-2025 | 14-Aug-2025 | Final | ₹3.00 |
EMCURE Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| MUKUND KESHAO GURJAR | Whole Time Director |
| SATISH RAMANLAL MEHTA | Chief Executive Officer |
| NAMITA VIKAS THAPAR | Whole-time Directorector |
Emcure Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Emcure Pharmaceuticals Ltd today is ₹1,910.10 on NSE and ₹1,910.10 on BSE.
- The 52-week high of Emcure Pharmaceuticals Ltd is ₹2,047.40, while the 52-week low is ₹1,260.10.
- The current market capitalisation of Emcure Pharmaceuticals Ltd is approximately ₹36,657 crore.
- The P/E (Price-to-Earnings) ratio of Emcure Pharmaceuticals Ltd is 31.10. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Emcure Pharmaceuticals Ltd is 5.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Emcure Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for EMCURE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Emcure Pharmaceuticals Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Emcure Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 77.83% promoters, -1.99% FIIs, 8.46% DIIs, and 6.45% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
